SNY.US Sanofi ADR

Healthcare Pharmaceuticals USA Stocks
47.67 USD
Close of Nov 17, 2026
39.07 48.98
Market cap
USD 114B
P/E
23.7x
P/B
1.44x
ROE
9.1%
Dividend yield
5.00%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SNY.US undervalued?

Graham number
Price47.67
Graham value38.74
Premium23.0%

SNY.US trades 23.0% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sanofi ADR fundamental analysis

No fundamental analysis for Sanofi ADR yet.

Sanofi ADR stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sanofi ADR

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions in Finland and Germany. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection; hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines; and Fluzone, a flu…

Full company profile